NVCR Covered Call Strategy
NVCR (Novocure Ltd), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
NVCR (Novocure Ltd) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $1.97B, a beta of 0.98 versus the broader market, a 52-week range of 9.82-21.451, average daily share volume of 1.7M, a public-listing history dating back to 2015, approximately 2K full-time employees. These structural characteristics shape how NVCR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.98 places NVCR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on NVCR?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
NVCR snapshot
As of August 14, 2026, spot at $16.99, ATM IV 63.00%, IV rank 32.06%, expected move 18.06%. The covered call on NVCR below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on NVCR specifically: NVCR IV at 63.00% is mid-range versus its 1-year history, so the credit collected on a NVCR covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 18.06% (roughly $3.07 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NVCR expiries trade a higher absolute premium for lower per-day decay. Position sizing on NVCR should anchor to the underlying notional of $16.99 per share and to the trader's directional view on NVCR stock.
NVCR covered call setup
The NVCR covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NVCR at $16.99 on that close, the first option leg uses a $18.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NVCR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NVCR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $16.99 | long |
| Sell 1 | Call | $18.00 | $1.08 |
NVCR covered call risk and reward
- Net Premium / Debit
- -$1,591.50
- Max Profit (per contract)
- $208.50
- Max Loss (per contract)
- -$1,590.50
- Breakeven(s)
- $15.91
- Risk / Reward Ratio
- 0.131
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
NVCR covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on NVCR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$1,590.50 |
| $3.77 | -77.8% | -$1,214.95 |
| $7.52 | -55.7% | -$839.40 |
| $11.28 | -33.6% | -$463.86 |
| $15.03 | -11.5% | -$88.31 |
| $18.79 | +10.6% | +$208.50 |
| $22.54 | +32.7% | +$208.50 |
| $26.30 | +54.8% | +$208.50 |
| $30.05 | +76.9% | +$208.50 |
| $33.81 | +99.0% | +$208.50 |
When traders use covered call on NVCR
Covered calls on NVCR are an income strategy run on existing NVCR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
NVCR thesis for this covered call
The market-implied 1-standard-deviation range for NVCR extends from approximately $13.92 on the downside to $20.06 on the upside. A NVCR covered call collects premium on an existing long NVCR position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether NVCR will breach that level within the expiration window. Current NVCR IV rank near 32.06% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on NVCR should anchor more to the directional view and the expected-move geometry. As a Healthcare name, NVCR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NVCR-specific events.
NVCR covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NVCR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NVCR alongside the broader basket even when NVCR-specific fundamentals are unchanged. Short-premium structures like a covered call on NVCR carry tail risk when realized volatility exceeds the implied move; review historical NVCR earnings reactions and macro stress periods before sizing. Always rebuild the position from current NVCR chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on NVCR?
- A covered call on NVCR is the covered call strategy applied to NVCR (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With NVCR stock at $16.99 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed NVCR chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are NVCR covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the NVCR covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 63.00%), the computed maximum profit is $208.50 per contract and the computed maximum loss is -$1,590.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NVCR covered call?
- The breakeven for the NVCR covered call priced on this page is roughly $15.91 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NVCR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 18.06%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on NVCR?
- Covered calls on NVCR are an income strategy run on existing NVCR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current NVCR implied volatility affect this covered call?
- NVCR ATM IV is at 63.00% with IV rank near 32.06%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.